Diagnostic chain Dr Lal PathLabs today reported 27.21 per cent rise in consolidated net profit to Rs 40.2 crore for the quarter ended March 31, 2018.
The company had posted a net profit of Rs 31.6 crore during January-March, 2016-17, Dr Lal PathLabs said in a filing to BSE.
Consolidated operating revenue rose to Rs 266.8 crore for the quarter under review. It was Rs 219.9 crore for the same period a year ago.
For entire 2017-18, the company's net profit rose to Rs 171.8 crore as against Rs 155.6 crore in 2016-17.
Consolidated operating revenue for the year stood at Rs 1,056.9 crore. It was Rs 912.4 crore in the previous financial year.
The company's board has recommended a final dividend of Rs 3 per equity share of Rs 10 each for 2017-18. This is in addition to the interim dividend of Rs 1.50 already paid out, Dr Lal PathLabs said.
Its shares today closed at Rs 806.10 per scrip on BSE, down 1.26 per cent from previous close.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app